Purchase Order HHSN268201700366A

<p>The National Heart Lung and Blood Institute awarded a purchase order to Vanderbilt University Medical Center for $79,648.00 on June 4, 2026, for dynamic genome research on clonal hematopoiesis of indeterminate potential (CHIP), severable in nature. Work is performed in Nashville, Tennessee. The order carries a firm fixed price structure with an ultimate completion date of June 3, 2027. No small business set-aside applies.</p>

This federal contract award to Vanderbilt University Medical Center (VUMC), a major academic medical center and nonprofit healthcare provider in Nashville, Tennessee, is for a project titled &quot;CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL (CHIP) CALLING.&quot; The $81,272 firm-fixed price purchase order was awarded on August 26, 2024 by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH). The contract has an ultimate completion date...

This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health National Heart Lung and Blood Institute to Vanderbilt University Medical Center (VUMC) for a &quot;GENE-FORECAST AND MH-GRID VALIDATION STUDY&quot; with a potential value of $114,834.35. The contract does not have a set-aside designation. VUMC is a nonprofit health care provider based in Nashville, Tennessee that has provided various goods and services to...

<p>The National Heart Lung and Blood Institute awarded a purchase order to University of Washington for $432,005.00 on August 30, 2019 for RNA sequencing of Framgiovanni Heart Study samples, with a firm fixed price and completion date of September 30, 2019. Place of performance is Bethesda, Maryland. No set-aside was used.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to the University of Chicago for $79,200 on February 27, 2018, for CLIA-approved genetic sequencing services, with final completion on February 26, 2019. Work is performed in Chicago, Illinois. Pricing is firm fixed price with no small business set-aside.</p>

This is a $52,662.05 firm-fixed price purchase order contract awarded by the National Human Genome Research Institute, a civilian agency, to Vanderbilt University Medical Center (VUMC) for a (CHIP) ASSAY ON 3000 DNA SAMPLES. The contract has no set-aside designation. VUMC is a major academic medical center and nonprofit healthcare provider based in Nashville, Tennessee that conducts extensive biomedical research and provides healthcare services. The contract was awarded based on a solicitation...

The National Heart Lung and Blood Institute awarded a purchase order to Medstar Health Research Institute Inc. for $23,925.00 on November 10, 2020, to process samples for NIH/Medstar Health Baltimore cell-free DNA COVID-19 research over an estimated one-year period. Performance occurs at University Park, Maryland. The order funds laboratory sample processing services in support of pulmonary function research conducted by Sean Agbor-Enoh and NHLBI pulmonary function lab staff, under firm...

The National Heart Lung and Blood Institute issued a $106,101.30 delivery order to Illumina, Inc. on September 2, 2026, for next-generation sequencing kits and reagents to support the NHLBI Sequencing Core Facility. Place of performance is San Diego, California. The order is firm fixed price with an ultimate completion date of September 2, 2026. The delivery order procures Illumina sequencing kits and reagents required to conduct next-generation sequencing on Illumina instruments for supported...

<p>The National Heart Lung and Blood Institute issued a purchase order to New York University School of Medicine valued at $11,864.00, awarded on March 7, 2018, with ultimate completion on March 14, 2019. The order is a firm fixed-price acquisition with no set-aside. Performance takes place in New York, NY. The source does not specify the goods or services procured.</p>

<p>The National Heart Lung and Blood Institute issued a $61,208.46 delivery order to Illumina, Inc. on September 14, 2015, for genetic sequencing and genomic analysis equipment and reagents.</p> <p>Place of performance is Bethesda, MD. The order carried a firm fixed-price structure with an ultimate completion date of September 2, 2020. No set-aside was used.</p>